Copyright 2022 – Synthekine
The Time for Cytokine Therapeutics Is Now
We believe that cytokine therapeutics engineered to be selective can fundamentally change the treatment paradigm of cancer and inflammatory disease.
The Pipeline to Advance Our Mission
Using our team’s cumulative expertise and our proprietary cytokine platforms, we are developing a broad, deep pipeline of selective immunotherapies against a wide range of important targets for the treatment of cancers and inflammatory diseases.